OPKO Health Long Term Debt 2010-2024 | OPK

OPKO Health long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
OPKO Health Annual Long Term Debt
(Millions of US $)
2023 $214
2022 $210
2021 $188
2020 $222
2019 $211
2018 $57
2017 $29
2016 $44
2015 $49
2014 $131
2013 $212
2012 $
2011 $25
2010 $
2009 $15
OPKO Health Quarterly Long Term Debt
(Millions of US $)
2024-09-30 $424
2024-06-30 $176
2024-03-31 $344
2023-12-31 $214
2023-09-30 $213
2023-06-30 $212
2023-03-31 $211
2022-12-31 $210
2022-09-30 $142
2022-06-30 $211
2022-03-31 $211
2021-12-31 $188
2021-09-30 $186
2021-06-30 $183
2021-03-31 $225
2020-12-31 $222
2020-09-30 $219
2020-06-30 $216
2020-03-31 $214
2019-12-31 $211
2019-09-30 $209
2019-06-30 $206
2019-03-31 $204
2018-12-31 $57
2018-09-30 $57
2018-06-30 $56
2018-03-31 $55
2017-12-31 $29
2017-09-30 $29
2017-06-30 $35
2017-03-31 $39
2016-12-31 $44
2016-09-30 $52
2016-06-30 $45
2016-03-31 $50
2015-12-31 $49
2015-09-30 $44
2015-06-30 $109
2015-03-31 $107
2014-12-31 $131
2014-09-30 $115
2014-06-30 $116
2014-03-31 $225
2013-12-31 $212
2013-09-30 $209
2013-06-30 $189
2013-03-31 $276
2012-12-31
2012-09-30 $33
2012-06-30 $23
2012-03-31 $22
2011-12-31 $25
2011-09-30 $2
2011-06-30 $2
2011-03-31 $2
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31 $15
2009-09-30 $15
2009-06-30 $14
2009-03-31 $14
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.106B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $194.739B 23.76
Intuitive Surgical (ISRG) United States $191.917B 100.34
Alcon (ALC) Switzerland $42.138B 28.19
Edwards Lifesciences (EW) United States $41.404B 26.29
IQVIA Holdings (IQV) United States $34.726B 19.13
IDEXX Laboratories (IDXX) United States $34.092B 40.15
DexCom (DXCM) United States $29.248B 44.05
STERIS (STE) Ireland $20.926B 24.09
Waters (WAT) United States $20.468B 30.26
SONOVA HOLDING (SONVY) Switzerland $20.297B 0.00
Hologic (HOLX) United States $18.250B 19.26
Fresenius Medical Care AG KGaA (FMS) Germany $12.969B 13.31
Sysmex ADR (SSMXY) Japan $12.688B 39.79
Globus Medical (GMED) United States $11.345B 28.73
Penumbra (PEN) United States $9.100B 89.14
Teleflex (TFX) United States $8.967B 14.30
Masimo (MASI) United States $8.754B 42.36
Glaukos (GKOS) United States $7.951B 0.00
PROCEPT BioRobotics (PRCT) United States $4.883B 0.00
Integer Holdings (ITGR) United States $4.479B 25.38
Veracyte (VCYT) United States $3.034B 91.05
Inari Medical (NARI) United States $2.984B 0.00
LivaNova (LIVN) United Kingdom $2.789B 16.10
TransMedics (TMDX) United States $2.783B 88.21
Nihon Kohden (NHNKY) Japan $2.293B 17.42
Elekta AB (EKTAY) Sweden $2.192B 17.86
Tandem Diabetes Care (TNDM) United States $1.830B 0.00
RxSight (RXST) United States $1.819B 0.00
Integra LifeSciences Holdings (IART) United States $1.766B 9.23
Alphatec Holdings (ATEC) United States $1.357B 0.00
Artivion (AORT) United States $1.129B 74.81
Pulse Biosciences (PLSE) United States $1.048B 0.00
Paragon 28 (FNA) United States $0.879B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.818B 13.91
ORTHOFIX MEDICAL INC (OFIX) United States $0.716B 0.00
IRadimed (IRMD) United States $0.650B 35.10
OrthoPediatrics (KIDS) United States $0.589B 0.00
AxoGen (AXGN) United States $0.561B 0.00
Mesa Laboratories (MLAB) United States $0.542B 12.77
SiBone (SIBN) United States $0.517B 0.00
Treace Medical Concepts (TMCI) United States $0.483B 0.00
Pacific Biosciences Of California (PACB) United States $0.471B 0.00
Tactile Systems Technology (TCMD) United States $0.378B 20.48
Semler Scientific (SMLR) United States $0.337B 22.60
CVRx (CVRX) United States $0.326B 0.00
Delcath Systems (DCTH) United States $0.317B 0.00
ClearPoint Neuro (CLPT) United States $0.303B 0.00
NeuroPace (NPCE) United States $0.274B 0.00
AngioDynamics (ANGO) United States $0.273B 0.00
Inogen (INGN) United States $0.226B 0.00
Sight Sciences (SGHT) United States $0.191B 0.00
Accuray (ARAY) United States $0.185B 0.00
Atossa Genetics (ATOS) United States $0.161B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
Nevro (NVRO) United States $0.159B 0.00
KORU Medical Systems (KRMD) United States $0.152B 0.00
Sensus Healthcare (SRTS) United States $0.137B 14.68
Spectral Diagnostics (EDTXF) Canada $0.112B 0.00
EDAP TMS S.A (EDAP) France $0.089B 0.00
WORK Medical Technology Group (WOK) China $0.088B 0.00
LENSAR (LNSR) United States $0.087B 0.00
908 Devices (MASS) United States $0.086B 0.00
Covalon Technologies (CVALF) Canada $0.078B 0.00
Monogram Orthopaedics (MGRM) United States $0.070B 0.00
InspireMD (NSPR) Israel $0.067B 0.00
EnVVeno Medical (NVNO) United States $0.063B 0.00
Hyperfine (HYPR) United States $0.063B 0.00
Lucid Diagnostics (LUCD) United States $0.057B 0.00
Vicarious Surgical (RBOT) United States $0.055B 0.00
Rapid Micro Biosystems (RPID) United States $0.047B 0.00
Accelerate Diagnostics (AXDX) United States $0.044B 0.00
Envoy Medical (COCH) United States $0.040B 0.00
Adagio Medical Holdings (ADGM) United States $0.035B 0.00
Precision Optics (POCI) United States $0.034B 0.00
Biosig Technologies (BSGM) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
Neuronetics (STIM) United States $0.023B 0.00
NexGel (NXGL) United States $0.022B 0.00
Spectral AI (MDAI) United States $0.021B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Baird Medical Investment Holdings (BDMD) $0.016B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.016B 0.00
Autonomix Medical (AMIX) United States $0.015B 0.00
QT Imaging Holdings (QTI) United States $0.012B 0.00
Aspira Women's Health (AWH) United States $0.011B 0.00
PAVmed (PAVM) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.010B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Avinger (AVGR) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00